PersonGen BioTherapeutics
PrivateLast Round
Series B
Jan 1, 2022
Total Funding Raised
$51.6M
Company Overview
PersonGen BioTherapeutics is a biotechnology company that develops innovative cellular immunotherapies, including CAR-T cell therapies, for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PersonGen BioTherapeutics Comparables
Compare PersonGen BioTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hebei Senlang Biotechnology Co., Ltd. | 88% | |
| Juventas Cell Therapy Ltd. | 86% | |
| AbelZeta Pharma | 84% | |
PersonGen BioTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 1, 2022 | ||||
| Series A | May 1, 2021 | ||||
| Strategic | Nov 11, 2015 | ||||
| Angel | Aug 1, 2012 |
PersonGen BioTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series A |
| YuanBio Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors grew 2789% MoM to 1.3K.
- Jan 1, 2022
$31M round led by Nanjing Huatai Guoxin and China Kim Kaide.
PersonGen BioTherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PersonGen BioTherapeutics's valuation, stock price, and market status.